Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroblastoma 11Brain Neoplasms 3Recurrence 2Osteosarcoma 2Multiple Myeloma 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Glioma 2Glioblastoma 2Diffuse Intrinsic Pontine Glioma 2Xanthomatosis, Cerebrotendinous 1Vaccinia 1Uveal Melanoma 1Transplant-Related Hematologic Malignancy 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Resectable Esophageal Cancer 1Prostatic Neoplasms 1Pathologic Complete Response 1Oligodendroglioma 1Neoplasms 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Influenza, Human 1

Interventions

Docetaxel 2Cisplatin 2130-nm albumin-bound paclitaxel 2taxane 1pembrolizumab 1liposomal doxorubicin 1durvalumab 1cemiplimab 1atezolizumab 1Pemetrexed 1Paclitaxel 1Nivolumab 1Granulocyte-Macrophage Colony-Stimulating Factor 1Biosimilar Pharmaceuticals 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaccinia × Granulocyte-Macrophage Colony-Stimulating Factor × 1 year × Clear all
NCT00629759 2026-05-19

A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

SillaJen, Inc.

Phase 1 Completed
14 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Vaccinia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡